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Abstract Site directed mutagenesis of the prohormone conver- 
tase PC2 was used to define the effect of certain residues on the 
zymogen activation of proPC2 and on its binding to the neuroen- 
docrine protein 7B2. These included the oxyanion hole Asp 3°9 
(D309N), the N-terminal Glu 25 (E25Q and E25K) of proPC2 and 
the Asp 519 (D519E) of the RGD motif within the P-domain of 
PC2. Heterologous vaccinia virus expression of the wild type and 
mutant PC2's in endocrine pituitary cells such as AtT20 and GH3 
cells demonstrated that the most dramatic effect was observed 
with the D309N mutant which no longer bound pro7B2 and which 
exhibited a significant reduction in its capacity to produce 6- 
endorphin from pro-opiomelanocortin (POMC). 
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vitro as an inhibitor of PC2 [16]. Subsequently, it was shown 
that intracellularly both pro7B2 [13,17] and 7B2 [13] can bind 
proPC2 and PC2. Heterologous cellular coexpression of 7B2 
with each of the convertases demonstrated that pro7B2/7B2 is 
a specific PC2-binding protein [13]. In the present work, we 
exploited the techniques of site directed mutagenesis and vac- 
cinia virus cellular expression to define the functional impor- 
tance of certain key amino acids within the proPC2 sequence. 
Accordingly, we examined the effect of these mutations on 
(i) the rate of intracellular p ocessing of proPC2 to PC2 and the 
participation of furin and PACE4 in this process, (ii) the ability 
of PC2 to produce fl-endorphin from pro-opiomelanocortin 
(POMC) and, (iii) the binding of proPC2/PC2 to pro7B2/7B2. 
2. Materials and methods 
1. In~oduction 
Tissue-specific processing of precursor proteins at single or 
pairs of basic residues i  a general mechanism by which organ- 
isms generate a diversity of bioactive ntities tarting from an 
inactive pro-protein [1,2]. The six convertases responsible for 
such specific cleavages have recently been identified and shown 
to be serine proteinases related to the subtilisin/kexin family 
and called furin, PC1/3, PC2, PACE4, PC4 and PC5/6 [1-5]. 
Analysis of the mode of biosynthesis of each convertase re- 
vealed that furin [3,6] and PCI [7-11] are themselves first syn- 
thesized as zymogens which undergo autocatalytic loss of their 
pro-segment within the endoplasmic reticulum (ER) and are 
then rapidly transported to the trans Golgi network (TGN) 
where they begin to exert their catalytic activities. In contrast 
to furin and PC1, the zymogen proPC2 slowly exits from the 
ER and is only processed to PC2 within the TGN [7,8,11-13] 
and such processing may continue in the secretory granules 
[11]. Concerning proPC2, it has been suggested that its process- 
ing to PC2 occurs either via an intermolecular utocatalytic 
mechanism [12] or that furin and/or PACE4 may participate in
this process [13]. Since the zymogen activation and inter-organ- 
elle rate of transport of the convertases represent mechanisms 
by which the cellular activity of these enzymes can be con- 
trolled, it was of interest to identify cellular factors which may 
participate in such a regulatory step. Recently, it was reported 
that the neuroendocrine precursor pro7B2 [14,15] can act in 
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2.1. Mutagenesis and the generation of recombinant vaccinia viruses 
Full length mouse PC2 (mPC2) cDNA [18] and m7B2 [19] were 
transferred tothe M13 vector M13mpl9 and the single strand copies 
were annealed with mutant oligonucleotides, and synthesis ofmutated 
double stranded DNA was performed using a mutagenesis kit from 
Biorad. The chosen mutants included the N-terminal of proPC2 Glu 25 
to either Gin (E25Q) or Lys (E25K); the oxyanion hole Asp 3°9 of PC2 
to Asn (D309N); the RGD 5~9 sequence to RGE (D519E) and the 
pro7B2 Lys 139 to Ala (K139A). The mutant double stranded cDNAs 
were then cloned into the transfer vector PMJ601 and recombinant 
vaccinia viruses (VV:) generated asreported [8,20]. 
2.2. Cellular infections, metabolic labeling and immunoprecipitations 
The endocrine cells AtT20 and GH3 were infected with the vaccinia 
virus recombinants VV :mPC2 and its mutants, VV : m7B2 and its mu- 
tant and VV:mPOMC as previously described [7,8]. Following VV 
infections and 17 h incubations, the cells were pulse labeled with either 
[35S]Met or Na2135SO4] and in some cases the radioactivity was chased 
for specified periods of time. Immunoprecipitations u der denaturing 
[7,8] or non-denaturing [13] conditions were essentially used as de- 
scribed. The antibodies used were the C-terminally directed mPC2 
fusion protein antibody [7,8], the 7B2 antibody directed against he 
segment 23-39 [15] and a ,8-endorphin specific antibody. The im- 
munoprecipitates were separated by SDS-PAGE using gels composed 
of either [8%T, 2.7%C], [12%T, 1.3%C], or [14%T, 6%C]-tricine and 
analysis by autoradiography was then performed. 
3. Results 
3.1. Analysis of the biosynthesis of proPC2 and its mutants in 
AtT20 cells 
In this study we wished to examine the functional importance 
of certain key amino acids in the control of the zymogen cleav- 
age of proPC2 into PC2 within the TGN. The amino acids 
chosen for mutation were selected from three distinct regions 
of the mouse proPC2 molecule including the prosegment Glu 25 
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to either Gln (E25Q) or Lys (E25K); the catalytic domain ox- 
yanion hole Asp 3°9 to Asn (D309N); and within the P-domain 
RGD 519 sequence to RGE (D519E). Accordingly, as a model 
of endocrine cells we chose AtT20 cells which were pulse-la- 
beled for 30 min with 35SO4 and then chased for 45 and 120 min 
(Fig. 1). This radiolabel was chosen, since we previously re- 
ported that PC2 is sulfated in the TGN at a specific Tyr residue 
[8], thus allowing us to assess both the rate of transport from 
the ER to the TGN and the processing of proPC2. As shown 
in Fig. 1, the intracellular processing of the wild type proPC2 
into the 71 and 68 kDa forms [8] is more than 50% complete 
at the 30 rain pulse period (P30). By contrast, all proPC2 mu- 
tants reveal a major proPC2 form at P30. Furthermore, the 
major processed form of wild type PC2 at each chase period 
was the 68 kDa form, whereas for the majority of the mutants 
the 71 kDa form predominates. Since microsequencing of the 
68 kDa form of PC2 [7] demonstrated that it represents the 
form which has lost all the 83 amino acid prosegment [18], it 
is possible that the 71 kDa form is extended at the N-terminus, 
as was previously suggested [7,8,12]. Relative to wild type PC2, 
we note that for all mutants the levels of the secreted 71 and 
68 kDa forms are lower and that the 71 kDa form predomi- 
nates. We also note that different from the wild type enzyme, 
all PC2-mutants seem to secrete much less PC2 and their intra- 
cellular levels dramatically decreased at the chase period of 120 
min. This is probably related to the fact that the mutations 
result primarily in the accumulation of the 71 kDa form which 
is not well secreted from AtT20 cells and, which may thus be 
intracellularly degraded with time, by an as yet unknown mech- 
anism. 
3.2. Processing of POMC by PC2 and its mutants in AtT20 and 
GH3 cells' 
In order to assess the functional consequences of the chosen 
mutations on the intracellular enzymatic activity of PC2, we 
chose to analyze the known processing of POMC by PC2 into 
fl-endorphin [21] in the regulated AtT20 and GH3 cells which 
express endogenously PC2 [5,18]. As shown in Fig. 2, relative 
to wild type PC2, with the exception of the RGD 5~9 variant 
(D519E), all mutants exhibit a significantly reduced capacity to 
process POMC (AtT20 and GH3 cells) and the intermediate 
fl-LPH (AtT20 cells) into fl-endorphin. The production of fl- 
LPH in AtT20 cells is due to their endogenous expression of 
PCI [18,21]. Therefore, these data are in general agreement 
with those deduced from Fig. 1, and together suggest hat the 
mutants D309N, E25Q and E25K produce lower amounts of 
bioactive PC2. Although the RGD mutation D519E slows 
down the processing of proPC2 to PC2 (Fig. 1), in the overex- 
pression system used this does not seem to exert a dominant 
effect on POMC processing by this mutant (Fig. 2). 
3.3. Binding of pro7B2/7B2 with proPC2/PC2 and its mutants 
in AtT20 cells 
We have recently reported that the 186 amino acid neuroen- 
docrine precursor pro7B2 and its 150 amino acid processed 
product 7B2 can both specifically bind proPC2 and PC2 [13]. 
Such binding was reported to be partially dependent on the 
integrity of the ArgLysArgArg j56 ~ Leu cleavage sequence of 
pro7B2 into 7B2. The ability of 7B2 to bind PC2, implies the 
presence of another binding site within the structure of 7B2 [13]. 
Since it was suggested that 7B2 exhibits ome sequence similar- 
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Fig. 1. Autoradiogram of a 8%T (2.7%C) SDS/PAGE slab gel of im- 
munoprecipitated media and extracts of AtT-20 cells infected with 
either wild type VV: mPC2 or the vaccinia virus recombinants of the 
PC2-mutants D309N, E25Q, E25K and D519E. The antibody used in 
this immunoprecipitation is directed against C-terminal 100 amino acid 
segment of mPC2 [7,8]. The AtT-20 cells were pulsed for 30 min (P30) 
and chased for 45 min (P30/C45) or 120 min (P30/C 120) with 35SO4. The 
positions of pro-PC2 (75 kDa), PC2 (71 kDa) and PC2 (68 kDa) are 
emphasized. 
ity to protease inhibitors and that the scissile bond of the reac- 
tive site of the inhibitor proteins aligns with the Lys139Lys 14° 
sequence of mouse 7B2 [16], we have also prepared a K139A 
mutant of pro7B2. The results of our analysis on the ability of 
the proPC2 mutants and/or the wild type proPC2 to bind 7B2 
and its mutant in AtT20 cells pulsed for 2 h with [35S]methionine 
are shown in Fig. 3. This autoradiogram represents an SDS- 
PAGE analysis of the 7B2/PC2 complexes immunoprecipitated 
under nondenaturing conditions with a 7B2 antibody. With the 
exception of the oxyanion hole mutant of PC2, all other mu- 
tants and their resulting proPC2/PC2 products bind equally 
well to 7B2. With this D309N mutant, 7B2 seems to only bind 
the 68 kDa form of PC2, which was further shown by microse- 
quencing to start at Gly ~°9 (not shown) following the major 
zymogen activation site of proPC2 [7]. We also note that the 
7B2 mutation K139A does not affect the binding of proPC2/ 
PC2 to 7B2 suggesting that the significance of the reported 
alignment to subtilase inhibitors [16] will have to be re-exam- 
ined. 
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Fig. 2. Autoradiogram of a 14%T (6%C)-tricine SDS/PAGE slab gel of the ]~-endorphin-immunoprecipitated media of AtT20 and GH3 cells infected 
with VV : mPOMC together with either wild type vaccinia virus (WT), with wild type VV : mPC2 or its mutants. The cells were pulse-labeled with 
[3SS]methionine for3 h. The migration positions of POMC, fl-LPH and fl-endorphin are shown. 
3.4. Processing of proPC2 and its mutants by furin and PACE4 
in AtT20 cells 
The analysis of a 3 h pulse with 35SO 4of AtT20 cells express- 
ing proPC2 or its mutants in the absence or presence of coex- 
pressed furin, PACE4 or 7B2 is shown in Fig. 4. We first note 
that furin and to a lesser extent PACE4 increase the level of 
processing of proPC2 into the 71 kDa form of PC2 both for 
native and mutants proPC2. We also note that all proPC2 
mutants can be partially cleaved by furin, and only for the 
D519E mutant by PACE4, into a 60 kDa form of PC2 which 
is not secreted. This suggests that the proPC2 mutants analyzed 
exhibit conformational changes which expose a cryptic furin- 
sensitive site. Finally, upon coexpression of pro7B2 with 
proPC2 or its mutants, we note that the PC2-specific C-termi- 
nal antibody used loses much of its capacity to immunoprecip- 
irate proPC2 or the 71 and 68 kDa forms of PC2. This suggests 
that the binding of 7B2 to PC2 diminishes the accessibility of 
the C-terminal segment of PC2 to the antibody, even under 
denaturing conditions. The mutants E25Q, E25K and espe- 
cially D519E partially restore the ability of the PC2-antibody 
to immunoprecipitate proPC2 in the presence of 7B2. In addi- 
tion, in the medium of the PC2 mutant D309N the major PC2 
secreted is the 71 kDa form. However, in the presence of co- 
expressed 7B2, the 68 kDa form is the predominant one, con- 
firming that the presence of 7B2 favors the formation of this 
form [13] even for the mutant D309N. 
4. Discussion 
The results presented in this work demonstrate hat all the 
mutations analyzed id not allow an increase in either the rate 
of zymogen processing of proPC2 into PC2, the transport of 
proPC2 to the TGN or the ability of this convertase to process 
POMC into fl-endorphin. Interestingly, with the exception of 
PC2, all subtilisin-like enzymes contain an Asn residue occupy- 
ing the oxyanion hole formed during catalysis [1-4]. In the case 
of PC2 this residue is occupied by Asp. Since it was shown that 
mutagenesis of subtilisin's [22] or kexin's [23] Asn into Asp 
caused a dramatic decrease in the catalytic efficiency of these 
enzymes, it was of interest o do the reverse experiment and 
replace the Asp 3°9 of PC2 by Asn 3°9. The results obtained with 
the D309N mutant clearly demonstrated that this Asp 3°9 is very 
critical for the PC2 activity, as its mutation to Asn lowers the 
capacity of the mutant PC2 to produce fl-endorphin from 
POMC (Fig. 2). Therefore, the suggestion that this Asp 3°9 de- 
creases the catalytic efficiency of PC2 at the expense of increas- 
ing its cleavage selectivity [23] does not seem to be true, as this 
D309N mutant is first of all less effective in producing fl-endor- 
phin and, it did not produce other products uch as fl-lipotropin 
which is generated by the Asn-containing furin, PC1 and 
PACE4. Furthermore, this mutation virtually eliminated the 
capacity of proPC2 to bind 7B2 (Fig. 3) or pro7B2 (not shown). 
These data suggest that Asp 3°9 is important for the binding of 
pro7B2 to proPC2 which starts in the ER [13]. 
Our results further defined the critical importance of the 
Glu 25 residue at the N-terminus of pro-PC2, as its mutation to 
either Lys or Gin (residues found at the N-terminus of either 
proPC 1 or profurin, respectively) significantly owered the abil- 
ity of proPC2 to be processed to the 68 kDa PC2, and favored 
the production of the 71 kDa form. These results suggest hat 
this Glu 25 residue is critical for the choice of the zymogen 
cleavage site within the pro-segment of proPC2. Such a cleav- 
age has been reported to be an intermolecular reaction occur- 
ring autocatalytically [12] or may require the participation of 
furin and/or PACE4 [13]. The data in Fig. 4, further suggest 
that furin enhances the production of the 71 kDa but not the 
68 kDa form, possibly suggesting that the cleavage producing 
the 71 kDa is mediated by a furin-like enzyme whereas that 
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resulting in the 68 kDa form may be autocatalytic [12,13]. In 
this context, it is worth noting that a very recent report demon- 
strated that the fusion of the 10 amino acid pro-peptide of the 
amidation enzyme PAM to the N-terminal Glu 25 of PC2 in- 
creased the exit rate of proPC2 from the ER [24]. From these 
and our results, it is possible that this reported effect is either 
due to the properties of the basic peptide sequence PheArgSer- 
ProLeuSerValPheLysArg- of proPAM [24], or that this pro- 
sequence masked the N-terminal 0t-NH 2 group of Glu 25. Since 
both Glu 2s mutants (Gin and Lys) rather showed a decreased 
rate of transport to the TGN, it is also possible that the negative 
charge of the side chain of Glu 2s is important for the correct 
folding of proPC2 within the ER. 
Since all the known mammalian convertases exhibit the pres- 
ence of a conserved RRGDL sequence within their P-domain 
[1,4] it was of interest to investigate the function of this se- 
quence in PC2 by site directed mutagenesis. The data presented 
in this work revealed that of all the mutants analyzed, the RGD 
mutant D509E demonstrated the least effect on either the zy- 
mogen processing of proPC2 (Fig. 1) or the cleavage of POMC 
into fl-endorphin (Fig. 2). However, this mutation increased the 
ability of PACE4 to cleave proPC2 into a 60 kDa form, possibly 
via exposure of a cryptic PACE4-site (Fig. 4). It remains to be 
established what (if any) is the function of this conserved RGD 
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Fig. 3. Autoradiogram of a 12%T (1.3%C) SDS/PAGE slab gel of 
7B2-immunoprecipitated (under non-denaturing conditions) media nd 
extracts of AtT-20 cells infected with VV : 7B2 and either VV : PC2 or 
its mutants. The two right lanes describe a similar experiment in which 
AtT20 cells were coinfected with wild type VV: PC2 and either wild type 
VV:7B2 or its mutant. The antibody used in these immunoprecipita- 
tions is directed against the peptide 23 39 of mouse 7B2 [15]. The AtT20 
cells were either pulsed for 2 h with [35S]Met or pulsed for 30 min and 
chased for 45 min for the KI39A mutant. The positions of pro-PC2 (75 
kDa), PC2 (68 kDa), pro7B2 (30 kDa) and 7B2 (23 kDa) are empha- 
sized. 
PC2 
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Fig. 4. Autoradiogram of an 8%T (2.7%C) SDS/PAGE slab gel of the 
PC2-immunoprecipitated media and cell extracts of AtT20 cells in- 
fected with either [VV: PC2 + VV: WT], [VV : PC2 + VV: furin], 
[VV : PC2 + VV: PACE4] or [VV: PC2 + VV: 7B2]. Equivalent infec- 
tions of the PC2-mutants were also performed. The cells were pulse- 
labeled with 35SO4 for 3 h. 
sequence and whether in PC2 and/or in the other convertases 
it may be important for the folding of the zymogen possibly via 
an interaction with integrins within the secretory pathway. 
In conclusion, the work presented here clearly showed that 
within the highly conserved primary structure of PC2, single 
amino acid substitutions can have dramatic effects on the zy- 
mogen activation of proPC2, its enzymatic activity and, its 
ability to interact with its specific binding protein 7B2. Future 
studies should unravel in more details the structure-function f 
proPC2/PC2 as well as the sequences involved in its recognition 
of pro7B2/7B2. 
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